Castellum (CTM) had the highest return between October 3, 2022 and November 3, 2022 by a US stock, returning 9,305.9%.
| ASSET | DATE | % RETURN |
|---|---|---|
Castellum (CTM) | 10/3/2022 - 11/3/2022 | 9,305.94% |
Huadi International (HUDI) | 10/3/2022 - 11/3/2022 | 319.52% |
SUNation Energy (SUNE) | 10/3/2022 - 11/3/2022 | 260% |
Cabaletta Bio (CABA) | 10/3/2022 - 11/3/2022 | 259.09% |
Biohaven Pharmaceutical (BHVN) | 10/3/2022 - 11/3/2022 | 131.46% |
Lottery (SEGG) | 10/3/2022 - 11/3/2022 | 118.54% |
Sellas Life Sciences (SLS) | 10/3/2022 - 11/3/2022 | 117.5% |
Spyre Therapeutics (SYRE) | 10/3/2022 - 11/3/2022 | 115.09% |
Immunovant (IMVT) | 10/3/2022 - 11/3/2022 | 110.23% |
TaoWeave (TWAV) | 10/3/2022 - 11/3/2022 | 107.14% |
Monopar Therapeutics (MNPR) | 10/3/2022 - 11/3/2022 | 102.61% |
TuanChe ADR (TC) | 10/3/2022 - 11/3/2022 | 102.51% |
Tango Therapeutics (TNGX) | 10/3/2022 - 11/3/2022 | 102.43% |
Avalo Therapeutics (AVTX) | 10/3/2022 - 11/3/2022 | 101.76% |
Heart Test Laboratories Inc Common Stock (HSCS) | 10/3/2022 - 11/3/2022 | 98.35% |
Rayonier Advanced Materials (RYAM) | 10/3/2022 - 11/3/2022 | 95.36% |
Universe Pharmaceuticals (UPC) | 10/3/2022 - 11/3/2022 | 90.74% |
Recon Technology (RCON) | 10/3/2022 - 11/3/2022 | 87.93% |
HeartCore Enterprises (HTCR) | 10/3/2022 - 11/3/2022 | 86.21% |
SS Innovations International Inc Common Stock (SSII) | 10/3/2022 - 11/3/2022 | 84.09% |
MYnd Analytics Inc (MYND) | 10/3/2022 - 11/3/2022 | 83.49% |
Vaxcyte (PCVX) | 10/3/2022 - 11/3/2022 | 82.94% |
Enliven Therapeutics (ELVN) | 10/3/2022 - 11/3/2022 | 82.68% |
Biovie (BIVI) | 10/3/2022 - 11/3/2022 | 78.66% |
Roivant Sciences (ROIV) | 10/3/2022 - 11/3/2022 | 71.07% |